National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Archive
2023
Difelikefalin (Kapruvia®). HTA ID: 23001
Olaparib (Lynparza®) in combination with bevacizumab (1L maintenance HRD positive ovarian cancer). HTA ID: 21011
Tixagevimab/cilgavimab (Evusheld®). HTA ID: 22074
Estriol (Blissel®) 50 micrograms per gram. HTA ID: 22071
Drospirenone/estetrol monohydrate (Drovelis®). HTA ID: 22073
2022
Oral Azacitidine (Onureg®). HTA ID: 22070
Eladocagene exuparvovec (UpstazaTM). HTA ID: 22072
Tixagevimab /cilgavimab (Evusheld®). HTA ID: 22015
Pembrolizumab (Keytruda®) for oesphageal carcinoma or HER-2 negative gastroesophageal junction adenocarcinoma . HTA ID: 21032
Amikacin Sulfate (Arikayce® liposomal nebuliser dispersion). HTA ID: 20048
Daratumumab (Darzalex®) in combination with cyclophosphamide, bortezomib and dexamethasone. HTA ID: 21041
Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) (Colorectal cancer). HTA ID: 21023
Maribavir (Livtencity®). HTA ID: 22069
Empagliflozin (Jardiance®). HTA ID: 22068
Bulevirtide (Hepcludex®). HTA ID: 22067
Axicabtagene ciloleucel (Yescarta®). HTA ID: 22066
Teclistamab (Tecvayli®). HTA ID: 22064
Olaparib ( Lynparza®) adjuvant treatment of early breast cancer. HTA ID:22065.
Pembrolizumab (Keytruda®) for colorectal cancer. HTA ID: 21002
Calcifediol monohydrate (Dnord®). HTA ID: 22063
Cenobamate (Ontozry®). HTA ID: 21025
Macimorelin acetate (Ghryvelin®). HTA ID: 22062
Faricimab (Vabysmo ®) for neovascular (wet) age-related macular degeneration. HTA ID: 22060
Faricimab (Vabysmo ®) for visual impairment due to diabetic macular oedema. HTA ID: 22061
Atidarsagene autotemcel (Libmeldy®). HTA ID: 21009
Entrectinib (Rozlytrek®). HTA ID: 22055
Anakinra (Kineret®). HTA ID: 22059.
Pegvaliase (Palynziq®) HTA ID: 21057
Niraparib (Zejula®); 1L maintenance OVCA. HTA ID: 21004
Buprenorphine prolonged-release solution for injection (Buvidal®). HTA ID: 22056
Lenvatinib (Kisplyx®). HTA ID: 22057
Tucatinib (Tukysa®). HTA ID: 22058
Eptinezumab (Vyepti®). HTA ID: 22052
Rimegepant (Vydura®). HTA ID: 22051
Nivolumab in combination with ipilimumab (Opdivo® and Yervoy®) (malignant pleural mesothelioma). HTA ID: 21018
Ibrutinib (Imbruvica®) in combination with venetoclax. HTA ID: 22054
Asciminib (Scemblix®) HTA ID: 22053
Upadacitinib (Rinvoq®). HTA ID: 22047
Capmatinib (Tabrecta®). HTA ID: 22049
Melatonin (Slenyto®). HTA ID: 22048
Mogamulizumab (Poteligeo®). HTA ID: 20061
Nivolumab (Opdivo®) for muscle invasive urothelial carcinoma. HTA ID: 22046
Nivolumab (Opdivo®)for unresectable, advanced, recurrent or metastatic oesophageal squamous cell carcinoma (OSCC) 1L. HTA ID: 22045
Ravulizumab (Ultomiris®) HTA ID: 20036
Vericiguat (Verquvo®). HTA ID: 21027
Tisagenlecleucel (Kymriah®). HTA ID: 22044
Trastuzumab deruxtecan (Enhertu®). HTA ID: 22050
Polatuzumab vedotin (Polivy®). HTA ID: 22043
Dapagliflozin (Forxiga®) for chronic kidney disease. HTA ID: 22040
Pembrolizumab (Keytruda®) adjuvant treatment of stage IIB or IIC melanoma. HTA ID: 22042
Pembrolizumab (Keytruda®) for persistent, recurrent or metastatic cervical cancer. HTA ID: 22041
Daratumumab (Darzalex®). HTA ID: 22039
Risankizumab (Skyrizi®) for psoriatic arthritis. HTA ID: 22038
Cholecalciferol (Egostar®). HTA ID: 22033
Carglumic acid (Ucedane®). HTA ID: 22035
Buprenorphine and naloxone (Zubsolv®). HTA ID: 22037
Pasireotide LAR (Signifor® LAR). HTA ID: 22034
Semaglutide (Wegovy®). HTA ID: 22029
Dapagliflozin (Forxiga®). HTA ID: 22030
Berotralstat (Orladeyo®). HTA ID: 22031
Atezolizumab (Tecentriq®) for adjuvant treatment of NSCLC. HTA ID: 22036
Vosoritide (Voxzogo®). HTA ID: 22028
Pembrolizumab (Keytruda®) for adjuvant treatment of RCC. HTA ID: 22026
Tepotinib (Tepmetko®). HTA ID: 22025
Ravulizumab (Ultomiris®). HTA ID: 19054
Andexanet alfa (Ondexxya®). HTA ID: 20014
Pembrolizumab (Keytruda®) for neoadjuvant/adjuvant treatment of triple negative breast cancer. HTA ID: 22027
Selumetinib (Koselugo®). HTA ID: 22032
Enzalutamide (Xtandi®) for nmCRPC. HTA ID: 18056
Enfortumab vedotin (Padcev®). HTA ID: 22024
Osilodrostat (Isturisa®). HTA ID: 22023
Ciltacabtagene autoleucel (Carvykti®). HTA ID: 22021
Cabozantinib (Cabometyx®) in combination with nivolumab (Opdivo®) for 1L RCC. HTA ID: 22018
Ivacaftor/tezacaftor/elexacaftor (Kaftrio®) HTA ID: 22022.
Abemaciclib (Verzenios®) for adjuvant HR positive, HER2 negative, node positive early breast cancer. HTA ID: 22020
Pomalidomide (Imnovid®) in combination with bortezomib and dexamethasone. HTA ID: 22016
Defatted powder of Arachis hypogaea L., semen (peanuts) (Palforzia®). HTA ID: 22019
Empagliflozin (Jardiance®). HTA ID: 21030
Solriamfetol (Sunosi®). HTA ID: 22017
Risdiplam (Evrysdi™). HTA ID: 21006
Caplacizumab (Cablivi®). HTA ID: 22013
Somatrogon (Ngenla®). HTA ID: 22010
Inclisiran (Leqvio®). HTA ID: 20051
Finerenone (Kerendia®). HTA ID: 22012
Trifluridine/tipiracil (Lonsurf®) for metastatic gastric cancer. HTA ID: 22011
Nirmatrelvir/Ritonavir (Paxlovid®). HTA ID: 22014
Avacopan (Tavneos®). HTA ID: 22009
Sacituzumab govitecan (Trodelvy®). HTA ID: 22007
Tofacitinib (Xeljanz®) for ankylosing spondylitis. HTA ID: 22005
Pembrolizumab (Keytruda®) in combination with lenvatinib (Lenvima®) for endometrial carcinoma. HTA ID: 22006
Apalutamide (Erleada®). HTA ID: 20010
Levodopa/carbidopa/entacapone intestinal gel (Lecigon®). HTA ID: 21068
Cefiderocol (Fetcroja®). HTA ID: 22003
Tafasitamab (Minjuvi®) in combination with lenalidomide. HTA ID: 22008
Inotersen (Tegsedi®). HTA ID: 19034
Dupilumab (Dupixent®) for severe asthma. HTA ID: 21063
Relugolix with estradiol and norethisterone acetate (Ryeqo®). HTA ID: 21055
Amivantamab (Rybrevant®). HTA ID: 22004
Venetoclax (Venclyxto®) for Acute Myeloid Leukaemia. HTA ID: 22001
Ozanimod (Zeposia®) for Ulcerative Colitis. HTA ID: 22002
Casirivimab/imdevimab (Ronapreve®). HTA ID: 21067
Encorafenib (Braftovi®) in combination with cetuximab. HTA ID: 20037
Pegcetacoplan (Aspaveli®). HTA ID: 21064
Sotorasib (Lumykras™). HTA ID: 21070
Oritavancin (Tenkasi®). HTA ID: 21061
Fedratinib (Inrebic®). HTA ID: 21069
Osimertinib (Tagrisso®) Adjuvant treatment stage IB-IIIA NSCLC. HTA ID: 21066
Lorlatinib (Lorviqua®) for 1L ALK positive NSCLC. HTA ID: 21071
Pembrolizumab (Keytruda®) for metastatic triple negative breast cancer. HTA ID: 21059
Cholic acid (Orphacol®). HTA ID: 21062
Regdanvimab (RegkironaTM). HTA ID: 21065
Bimekizumab (Bimzelx®). HTA ID: 21052
2021
Molnupiravir (Lagevrio®). HTA ID: 21060
Abrocitinib (Cibinqo®) HTA ID: 21056
Mometasone furoate plus olopatadine (Ryaltris®). HTA ID: 21051
Avelumab (Bavencio®) 1L maintenance urothelial carcinoma. HTA ID: 21001
Odevixibat (Bylvay®). HTA ID: 21058
Alpelisib (Piqray®) HTA ID: 20035
Diroximel fumarate (Vumerity®). HTA ID 21047
Baricitinib (Olumiant®) for atopic dermatitis. HTA ID: 21050
Ketoconazole (Ketoconazole HRA®). HTA ID: 21046
Filgotinib (Jyseleca®) HTA ID:21048
Latanoprost/Timolol (Fixapost®) HTA ID: 21053
Tirbanibulin (Klisyri®). HTA ID: 21054
Dostarlimab (Jemperli®). HTA ID: 21045
Nivolumab (Opdivo®) for advanced or metastatic gastric, gastro oesophageal junction or oesophageal adenocarcinoma (1L). HTA ID: 21049.
Tildrakizumab (Ilumetri®). HTA ID: 19029
Larotrectinib (Vitrakvi ®) HTA ID: 19050
Zanubrutinib (Brukinsa®). HTA ID: 21044
Daratumumab (Darzalex®) HTA ID: 20025
Bempedoic acid/Ezetimibe (Nustendi®) HTA ID: 20026b
Bempedoic acid (Nilemdo®) HTA ID: 20026a
Pegylated liposomal irinotecan (Onivyde®) HTA ID: 20028
Hydrocortisone modified-release hard capsules (Efmody®). HTA ID: 21042
Brentuximab vedotin (Adcetris®) for CD30+ Hodgkins lymphoma HTA ID: 19058
Nivolumab (Opdivo®) for adjuvant treatment of oesophageal or gastro-oesophageal junction cancer. HTA ID: 21043
Upadacitinib (Rinvoq®) for psoriatic arthritis. HTA ID: 21040
Upadacitinib (Rinvoq®) for ankylosing spondylitis. HTA ID: 21039
Ponesimod (Ponvory®). HTA ID: 21036
Roxadustat (Evrenzo™). HTA ID: 21037
Entrectinib (Rozlytrek®) for ROS1-positive advanced NSCLC. HTA ID: 21038
Dupilumab (Dupixent®) for severe atopic dermatitis in children 6 to 11 years old. HTA ID: 21035
Darolutamide (Nubeqa®). HTA ID: 20022
Durvalumab (Imfinzi®) for 1L extensive-stage small cell lung cancer. HTA ID 21033
Tofacitinib (Xeljanz®) for active polyarticular juvenile idiopathic arthritis. HTA ID: 21034
Venetoclax (Venclyxto®) in combination with obinutuzumab (Gazyvaro®). HTA ID: 20046
Risankizumab (Skyrizi®) HTA ID: 19010
Blinatumomab (Blincyto®). HTA ID: 21031
Upadacitinib (Rinvoq®) for atopic dermatitis. HTA ID: 21029
Tralokinumab (Adtralza®). HTA ID: 21028
Ruxolitinib (Jakavi®) for Polycythaemia Vera. HTA ID: 20008
Cabotegravir (Vocabria®) in combination with rilpivirine (Rekambys®). HTA ID: 21026
Delta-9-tetrahydrocannabinol/Cannabidiol, THC/CBD (Sativex®)
Cannabidiol (Epidyolex®) for the treatment of Tuberous Sclerosis Complex. HTA ID: 21024
Selpercatinib (Retsevmo®) for advanced RET fusion-positive thyroid cancer. HTA ID: 21020b
Selpercatinib (Retsevmo®) for advanced RET-mutant medullary thyroid cancer. HTA ID: 21020a
Enzalutamide (Xtandi®) for mHSPC. HTA ID: 21022
Selparcatinib (Retsevmo®) for NSCLC. HTA ID: 21021
Nintedanib (Ofev®) HTA ID: 20034
Avelumab (Bavencio®) in combination with axitinib (Inlyta®) for first line treatment of metastatic renal cell carcinoma. HTA ID: 19046
Olaparib (Lynparza®) for mCRPC. HTA ID: 21019
Conestat alfa (Ruconest®). HTA ID: 21017
Romosozumab (Evenity®). HTA ID: 21016
Pembrolizumab (Keytruda®) for head and neck squamous cell carcinoma. HTA ID: 19051
Pembrolizumab (Keytruda®) for classical Hodgkin Lymphoma. HTA ID: 21013
Neratinib (Nerlynx®) HTA ID: 19057
Onasemnogene abeparvovec (Zolgensma®). HTA ID: 20021
Nivolumab plus Ipilimumab plus platinum-doublet chemotherapy (Opdivo® plus Yervoy®) (1L NSCLC). HTA ID: 21014
Formoterol fumarate dihydrate, glycopyrronium, budesonide (Trixeo Aerosphere®). HTA ID: 21015
Brentuximab vedotin (Adcetris®). HTA ID: 21010
Atezolizumab (Tecentriq®) for 1L NSCLC. HTA ID: 21012
Ofatumumab (Kesimpta®). HTA ID: 21008
Cemiplimab (Libtayo®). HTA ID: 21007
Autologous anti-CD19-transduced CD3+ cells (Tecartus®). HTA ID: 21005
Trastuzumab emtansine (Kadcyla®) HTA ID: 20002
Esketamine (Spravato®) HTA ID: 19055
Cannabidiol (Epidyolex®) for the treatment of Lennox-Gastaut Syndrome. HTA ID: 20005
Cannabidiol (Epidyolex®) for the treatment of Dravet Syndrome. HTA ID: 20004
Ceftazidime/avibactam (Zavicefta®). HTA ID: 21003
Gilteritinib (Xospata®) for Relapsed or Refractory AML. HTA ID: 19043
Siponimod (Mayzent®) HTA ID: 19053
IUB™ Ballerine® MIDI 15mm diameter SCU300B. HTA ID: 20062
Guselkumab (Tremfya®) for psoriatic arthritis. HTA ID 20059
Semaglutide (Rybelsus®) HTA ID: 20011
Polatuzumab vedotin (Polivy®) HTA ID: 19052
Avatrombopag (Doptelet®). HTA ID: 20058
Omeprazole (Pedippi®) 2mg/ml powder for oral suspension (HTA ID: 20049)
Liraglutide (Saxenda®) HTA ID: 19039
Atezolizumab (Tecentriq®) in combination with bevacizumab. HTA ID: 20060
Acalabrutinib (Calquence®) HTA ID: 20063
Baricitinib (Olumiant®) for moderate to severe atopic dermatitis. HTA ID: 20056
Opicapone (Ongentys®). HTA ID: 20055
Carfilzomib (Kyprolis®) in combination with daratumumab and dexamethasone (CAR+DAR+DEX). HTA ID: 20054
Nivolumab (Opdivo®) as monotherapy for unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma (2L). HTA ID: 20057
Galcanezumab (Emgality®). HTA ID 20052
Pertuzumab and trastuzumab (Phesgo®). HTA ID: 20053
2020
Fluocinolone acetonide intravitreal implant (Iluvien®) for non-infectious uveitis. HTA ID: 20050
Pembrolizumab (Keytruda®) in combination with axitinib (Inlyta®) for 1L RCC. HTA ID: 19027
Ozanimod (Zeposia®). HTA ID: 20045
Sodium hydrogen carbonate (Thamicarb®). HTA ID: 20043
Delafloxacin (Quofenix®). HTA ID: 20038
Filgotinib (Jyseleca®). HTA ID: 20047
Nusinersen (Spinraza®). HTA ID: 20044
Imipenem/cilastatin/relebactam (Recarbrio®). HTA ID: 20040
Infliximab (Remsima® subcutaneous). HTA ID: 20042
Glasdegib (Daurismo®) in combination with low-dose cytarabine. HTA ID: 20041
Tafamidis (Vyndaqel®). HTA ID: 20017
Atezolizumab (Tecentriq®) in combination with carboplatin and etoposide for 1L ES-SCLC HTA ID: 19030
Atezolizumab (Tecentriq®) HTA ID: 20039
Voretigene neparvovec (Luxturna®) HTA ID: 19041
Talazoparib (Talzenna®) HTA ID: 19032
Fremanezumab (Ajovy®)
Atezolizumab (Tecentriq®) for triple-negative breast cancer.
Abemaciclib (Verzenios®) HTA ID: 20033
Dabrafenib plus Trametinib (Tafinlar® plus Mekinist®)
Vedolizumab (Entyvio®) HTA ID: 20029
Vedolizumab (Entyvio®) HTA ID: 20030
Brigatinib (Alunbrig®) HTA ID: 20031
Apalutamide (Erleada®) for nmCRPC
Ibrutinib (Imbruvica®) HTA ID:20032
IUB™ Ballerine® MIDI 15mm diameter SCU300B. HTA ID: 20027
Lanadelumab (Takhzyro®)
Indacterol/mometasone furoate (Atectura®) HTA ID: 20024
Indacterol/glycopyrronium/mometasone furoate (Enerzair®). HTA ID: 20023
Letermovir (Prevymis®)
Pembrolizumab (Keytruda®) for Adjuvant melanoma
Hydroxycarbamide solution (Xromi®). HTA ID: 20020
Naloxone (Nyxoid®) intranasal spray. HTA ID: 20019
Durvalumab (Imfinzi®)
House Dust Mite Extract (Acarizax ®) for Allergic Asthma. HTA ID: 20016
House Dust Mite Extract (Acarizax ®) for Allergic Rhinitis. HTA ID: 20015
Benralizumab (Fasenra®) Autoinjector. HTA ID: 20018.
Liposomal daunorubicin and cytarabine (Vyxeos Liposomal®)
Estradiol (Oestrogel® Pump Gel). HTA ID: 20013
Brolucizumab (Beovu®). HTA ID: 20009
Meropenem/vaborbactam (Vaborem®). HTA ID: 20007
Avatrombopag (Doptelet®). HTA ID: 20006
Olaparib (Lynparza®) (1L maintenance of BRCA-mutated advanced OVCA)
Infliximab (Remsima SC®). HTA ID: 20012
Pegaspargase (Oncaspar®) powder for solution for injection/infusion. HTA ID: 20003
Burosumab (Crysvita®)
Alutard SQ® honey bee and Alutard SQ® wasp venoms. HTA ID: 19038
Patisiran (Onpattro®)
Axicabtagene Ciloleucel (Yescarta®)
Pegvaliase (Palynziq®) HTA ID: 20001
Lutetium (177Lu) Oxodotreotide (Lutathera®)
Olaparib (Lynparza®) for platinum sensitive relapsed ovarian cancer
Dupilumab (Dupixent®) for moderate-to-severe atopic dermatitis in adolescent patients. HTA ID: 19056
Co-enzyme Q10 (CoQun®) HTA ID: 19045
Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®)
Fluoride toothpaste (Duraphat® 5,000 ppm)
2019
Methyl aminolevulinate (Metvix®) HTA ID: 19049
Ustekinumab (Stelara®) for Ulcerative colitis HTA ID: 19048
Dupilumab (Dupixent®)
Upadacitinib (Rinvoq®) HTA ID: 19047
Midostaurin (Rydapt®) for AML
Progesterone (micronised) (Utrogestan®)
Certolizumab pegol (Cimzia ®) for moderate to severe plaque psoriasis
Venetoclax (Venclyxto®) in combination with rituximab
Mepolizumab (Nucala®) 100mg solution in pre-filled pen and syringe
Levonorgestrel Intrauterine System (Levosert®)
Zanamivir (Dectova®)
Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of adults with melanoma
Argipressin acetate (Embesin®)
Trientine Tetrahydrochloride (TETA 4HCL) – Cuprior®
Erenumab (Aimovig®)
Darvadstrocel (Alofisel®)
Blinatumomab (Blincyto®) CD19+ BCP-ALL
Tisagenlecleucel (Kymriah®) for DLBCL
Tisagenlecleucel (Kymriah®) for pALL
Dolutegravir/Lamivudine (Dovato®)
Doxylamine/Pyridoxine (Xonvea®)
Pembrolizumab (Keytruda®) 1L NSCLC with chemotherapy
Niraparib (Zejula®); Recurrent OVCA maintenance treatment
Olaparib (Lynparza®) tablets for BRCA-mutated platinum sensitive relapsed ovarian, fallopian tube, or primary peritoneal cancer
Osimertinib (Tagrisso®) for the first-line treatment of metastatic NSCLC
Romiplostim (Nplate®)
Ribociclib (Kisqali®) – Updated License
Gemtuzumab ozogamicin (Mylotarg®)
Lorlatinib (Lorviqua®)
Rivaroxaban (Xarelto®) for the prevention of atherothrombotic events
Levodopa 20mg/ml + carbidopa monohydrate 5mg intestinal gel (Duodopa®)
Atezolizumab (Tecentriq® ) for Urothelial Carcinoma 2L
Vestronidase alfa (MEPSEVII®)
Magnesium Aspartate Dihydrate (Magnaspartate®)
Dacomitinib (Vizimpro®)
Stiripentol (Diacomit®)
Mannitol Dry Powder (Bronchitol®)
Olaparib (Lynparza®) for breast cancer
Opium Tincture (Dropizol®
Pembrolizumab (Keytruda ®) 1L squamous NSCLC with chemotherapy
Cerliponase alfa (Brineura®)
Pembrolizumab (Keytruda ®) for Urothelial Carcinoma 2L
Carfilzomib (Kyprolis®) in combination with dexamethasone (CAR+DEX).
Daratumumab (Darzalex®) in combination with bortezomib and dexamethasone
Liraglutide (Victoza®)
Patiromer (Veltassa®)
Pertuzumab (Perjeta®) for Adjuvant HER2 positive breast cancer
Blinatumomab (Blincyto®) (paediatric ALL)
Budesonide orodispersible tablet (Jorveza®)
Pentosan Polysulfate Sodium [PPS] (Elmiron®)
Tivozanib (Fotivda®)
Encorafenib (Braftovi®), binimetinib (Mektovi®)
Diclofenac (Itami®)
Doravirine (Pifeltro®)
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (Delstrigo®)
Alectinib (Alecensa®)
2018
Cariprazine (Reagila®)
Ozenoxacin (Dubine®)
Ropivacaine Readyfusor®
Brigatinib (Alunbrig®)
Lesinurad (Zurampic®)
Ixekizumab (Taltz®) for psoriatic arthritis
Abiraterone acetate (Zytiga®) for mHSPC
Dinutuximab beta (Qarziba®)
Avelumab (Bavencio®)
Ocrelizumab (Ocrevus®) for PPMS
Atezolizumab (Tecentriq®)
Tofacitinib (Xeljanz®) for Ulcerative Colitis
Inotuzumab ozogamicin (Besponsa®)
Nivolumab (Opdivo®) for urothelial carcinoma
Tolvaptan (Jinarc®)
Midostaurin (Rydapt®) for ASM
Idebenone (Raxone®)
Ocrelizumab (Ocrevus®) for RMS
Lenvatinib (Lenvima®) for HCC
Ribociclib (Kisqali®)
Pembrolizumab (Keytruda ®) for Urothelial Carcinoma 1L
Urea (GlucoRx Allpresan®)
Cladribine (Mavenclad®)
Dolutegravir/Rilpivirine (Juluca®)
Cabozantinib (Cabometyx®)
Venetoclax (Venclyxto®)
Glycerol Phenylbutyrate (Ravicti®)
Fluticasone furoate/ umeclidinium/ vilantero (Trelegy™ Ellipta™)
Sebelipase alfa (Kanuma®)
Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy®)
Pembrolizumab (Keytruda®) for NSCLC (second line)
Selexipag (Uptravi®)
Ertugliflozin (Steglatro®)
Recombinant Human Parathyroid Hormone (Natpar®)
Evolocumab (Repatha®)
Tafamidis meglumine (Vyndaqel®)
Naltrexone / bupropion (Mysimba®)
Osimertinib (Tagrisso®)
Obinutuzumab (Gazyvaro®) for previously untreated advanced follicular lymphoma
Eliglustat (Cerdelga®)
Blinatumomab (Blincyto®)
Semaglutide (Ozempic®)
Teduglutide (Revestive®)
Brentuximab vedotin (Adcetris®) for CD30+ cutaneous T-cell lymphoma (CTCL)
Benralizumab (Fasenra®)
Dimethyl fumarate (Skilarence®)
Guselkumab (Tremfya®)
Modified Release Hydrocortisone (Plenadren®)
2017
Pembrolizumab (Keytruda ®) for Classical Hodgkin Lymphoma
Emtricitabine/tenofovir disoproxil (TEVA®)
Nusinersin (Spinraza®)
Ixazomib (Ninlaro®)
Tramadol hydrochloride/dexketoprofen (Skudexa®)
Hyaluronic acid and co enzyme Q10 (VisuXL®)
Daratumumab (Darzalex®) in combination with lenalidomide and dexamethasone
Rivaroxaban (Xarelto®) low dose for prevention of recurrent venous thromboembolism
Rivaroxaban (Xarelto®) for Atrial Fibrillation patients undergoing PCI
Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi®)
Cysteamine bitartrate delayed-release (Procysbi®)
Lacosamide (Vimpat ®)
Obeticholic acid (Ocaliva®)
Darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide (Symtuza®)
Sofosbuvir/Velpatasvir (Epclusa®) chronic hepatitis C virus (HCV) – pangenotypic
Pembrolizumab (Keytruda®) for NSCLC (first line)
Sarilumab (Kevzara®)
Sapropterin (Kuvan®)
Etelcalcetide (Parsabiv®)
Glecaprevir/Pibrentasvir (Maviret®)
Brodalumab (Kyntheum®)
Follitropin delta (Rekovelle®)
Palbociclib (Ibrance®)
Emtricitabine / tenofovir disoproxil fumarate (Truvada®)
Baricitinib (Olumiant®)
Pitolisant hydrochloride (Wakix®)
Insulin aspart (Fiasp®)
Bezlotoxumab (Zinplava®)
Ceftazidime-avibactam (CEF-AVI)(Zavicefta®)
Rolapitant (Varuby®)
Human alpha1-proteinase inhibitor (A1PI) (Prolastin®)
Alirocumab (Praluent®)
Migalastat (Galafold®)
Lenvatinib (Kisplyx®)
Nivolumab (Opdivo®) for head and neck cancer
Dalbavancin (Xydalba®)
Tofacitinib (Xeljanz®)
Everolimus (Votubia ®) for refractory seizures associated with tuberous sclerosis complex (TSC)
Crizotinib (Xalkori®) for ROS1 NSCLC
Crizotinib (Xalkori®) for first line ALK+ NSCLC
Glycopyrronium bromide (Sialanar®)
Nivolumab (Opdivo®) for advanced renal cell carcinoma
Levonorgestrel intrauterine delivery system LNG IUS 12 (Kyleena®)
Trametinib (Mekinist®)
Daratumumab (Darzalex®)
Mepolizumab (Nucala®) 100mg powder for solution for injection
Reslizumab (Cinqaero®)
Amsacrine (Amsidine®)
Epoprostenol (Veletri®)
Obinutuzumab (Gazyvaro®) for Follicular Lymphoma
Nivolumab (Opdivo®) for classical Hodgkin Lymphoma
Ustekinumab (Stelara®) for Crohn’s Disease
Cobimetinib (Cotellic®)
Ivacaftor (Kalydeco®) for the treatment of CF patients with the R117H mutation.
2016
Phenylephrine Hydrochloride, Tropicamide & Lidocaine Hydrochloride (Fydrane®)
Human alpha1-proteinase inhibitor (Respreeza®)
Elosulfase alfa (Vimizim®)
Daclizumab (Zinbryta®)
Vortioxetine (Brintellix®)
Nivolumab plus ipilimumab (Opdivo® plus Yervoy®)
Carfilzomib (Kyprolis®) in combination with lenalidomide and dexamethasone (CAR+LEN+DEX)
Insulin degludec/liraglutide (IDegLira) (Xultophy®)
Elbasvir/Grazoprevir (Zepatier®)
Ivacaftor (Kalydeco®) for patients with CF 2 years +
Nivolumab (Opdivo®) for non-squamous NSCLC
Ferric maltol (Feraccru®)
Aceclofenac (Vitafen®)
Ibrutinib (Imbruvica®) for previously untreated CLL
Sofosbuvir/Velpatasvir (Epclusa®)
Loxapine inhalation powder (Adasuve®)
Ixekizumab (Taltz®)
Ramucirumab (Cyramza®)
Trifluridine/tipiracil (Lonsurf®)
Rilpivirine (R), emtricitabine (F), tenofovir alafenamide (TAF) (Odefsey®)
Sacubitril/valsartan (Entresto®)
Safinamide methansulfonate (Xadago®)
Calcipotriol and betamethasone dipropionate cutaneous foam (Enstilar ®)
Lumacaftor/ivacaftor (Orkambi®)
Ulipristal acetate (Esmya ®) intermittent treatment
Etanercept (Benepali®)
Pertuzumab (Perjeta®) in neoadjuvant HER2 positive breast cancer
Isavuconazole (Cresemba®) for the treatment of invasive aspergillosis.
Isavuconazole (Cresemba®) for the treatment of mucormycosis
Ticagrelor (Brilique®)
Apremilast (Otezla®) for psoriatic arthritis.
Ataluren (Translarna®)
Emtricitabine/tenofovir alafenamide (Descovy®)
Ceftolozane/tazobactam (Zerbaxa®)
Nintedanib (Vargatef®)
Brivaracetam (Briviact®)
Sufentanil (Zalviso®)
Nivolumab (Opdivo®) for Melanoma
Talimogene Laherparepvec (Imlygic®)
Nivolumab (Opdivo®) for NSCLC
Levofloxacin (Quinsair®)
Fluocinolone acetonide intravitreal implant (Iluvien®) for diabetic macular oedema
Eltrombopag (Revolade®) for Severe Aplastic Anaemia (SAA)
Nintedanib (Ofev®)
Idelalisib (Zydelig®)
Paritaprevir boosted with ritonavir and ombitasvir (Vierkirax®) with or without dasabuvir (Exviera®)
Panobinostat (Farydak®)
Pembrolizumab (Keytruda®) for the first line treatment of unresectable or advanced metastatic melanoma in adults.
Pembrolizumab (Keytruda®) for the treatment of unresectable or advanced metastatic melanoma in adults refractory to ipilimumab.
Apremilast (Otezla®) for moderate to severe chronic plaque psoriasis.
Ciclosporin 1mg/ml eye drops (Ikervis®)
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide (Genvoya®)
Ponatinib (Iclusig®)
2015
Methoxyflurane (Penthrox®)
Guanfacine hydrochloride (Intuniv®)
Idarucizumab (Praxbind®)
Olaparib (Lynparza®) capsules for BRCA-mutated platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer
Secukinumab (Cosentyx®) for Psoriatic Arthritis
Secukinumab (Cosentyx®) for Ankylosing Spondylitis
Lenalidomide (Revlimid®)
Iron (III) isomaltoside 1000 (Monover®)
Iron (III) isomaltoside 1000 (Diafer®)
Ledipasvir/sofosbuvir (Harvoni®)
Vedolizumab (Entyvio®) in Ulcerative Colitis
Vedolizumab (Entyvio®) in Crohn’s Disease
Netupitant/palonosetron (Akynzeo®)
Insulin Glargine (Abasaglar®)
Ibrutinib (Imbruvica®) for MCL
Ibrutinib (Imbruvica®) for CLL
Lidocaine 5% plasters (Versatis®)
Secukinumab (Cosentyx®) for moderate to severe plaque psoriasis
Tedizolid phosphate (Sivextro®)
Ceritinib (Zykadia®)
Camellia sinensis, folium (green tea leaf) (Catephen 10%®)
Lenvatinib (Lenvima®)
Edoxaban (Lixiana®)
Insulin Glargine U300 (Toujeo®)
Omalizumab (Xolair®) for the treatment of severe allergic asthma
Enzalutamide (Xtandi®) pre chemotherapy
Daclatasvir (Daklinza®)
St Johns Wort (Pacifa®)
Insulin Degludec (Tresiba®)
Dulaglutide (Trulicity®)
Naloxegel (Moventig®)
Obinutuzumab (Gazyvaro®) for Lymphocytic Leukaemia
Pixantrone (Pixuvri®)
Simeprevir (Olysio®) in combination with Sofosbuvir
Pomalidomide (Imnovid®)
Bedaquiline (Sirturo®)
Aclidinium bromide / formoterol fumarate dihydrate (Brimica® Genuair®)
Dimethyl fumarate (Tecfidera®)
Telavancin (Vibativ®)
Darunavir & cobicistat (Rezolsta®)
2014
Pegylated Interferon beta-1a (Plegridy ®)
Ofatumumab (Arzerra®) (Previously untreated Chronic Lymphocytic Leukaemia)
Pregabalin (Lyrica®) for the treatment of Generalised Anxiety Disorder
Radium-223 (Xofigo®)
Sofosbuvir (Solvaldi®)
Polynuclear iron(III)-oxyhydroxide (pn-FeOOH) (Velphoro®)
Regorafenib (Stivarga®) for GIST
Rituximab (MabThera®)
Lomitapide (Lojuxta®)
Nab-paclitaxel (Abraxane®)
Canagliflozin (Invokana®)
Insulin aspart (NovoRapid® FlexTouch ®)
Apixaban (Eliquis®) for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
Cabozantinib (Cometriq®)
Aripiprazole (Abilify Maintena®)
Lixisenatide (Lyxumia®)
Tocilizumab SC (RoActemra®)
Defibrotide (Defitelio®)
Simeprevir (Olysio®)
Umeclidinium/vilanterol (Anoro®)
Bosentan (Tracleer®)
Ambrisentan (Volibris®)
Alemtuzumab (Lemtrada®)
Trastuzumab emtansine (Kadcyla®)
Dabrafenib (Tafinlar®)
Regorafenib (Stivarga®) for mCRC
Buprenorphine/naloxone (Suboxone®)
Teriflunomide (Aubagio®)
Omalizumab (Xolair®)
Dabigatran Etexilate (Pradaxa®) for the treatment of DVT and PE
Empagliflozin (Jardiance®)
Tadalafil (Adcirca®)
Sildenafil (Revatio®)
Riociguat (Adempas®)
Brimonidine 3.3 mg/g gel (Mirvaso®)
Clindamycin 1% with tretinoin 0.025% (Treclinac®)
Oladaterol (Striverdi®, Respimat®)
Avanafil (Spedra®)
Brentuximab vedotin (Adcetris®)
Enzalutamide (Xtandi®) on or after chemotherapy
Nalmefene (Selincro®)
Sodium Chloride 70mg/ml, Sodium Hyaluronate 1mg/ml (Hyaneb®)
Dolutegravir (Tivicay®)
Abiraterone acetate (Zytiga®) for mCRPC post ADT
Incobotulinum Toxin Type A (Xeomin®)
Meningitis B Vaccine – February 2014
Eltrombopag (Revolade®) for Thrombocytopenia in HCV
Aflibercept (Zaltrap®)
Macitentan (Opsumit®)
Liquid Paraffin Ointment (VitA-POS Opthalmic®)
Sodium Hyaluronate (Hyloforte® 0.2%)
Sodium Hyaluronate (Hylotear® 0.1%)
Vismodegib (Erivedge®)
2013
Dapagliflozin (Forxiga®)
Fluticasone furoate/vilanterol (Relvar™ Ellipta™)
Abatacept (Orencia®)
Alogliptin (Vipidia®)
Golimumab (Simponi®) for UC
Pregabalin (Lyrica®) for the treatment of neuropathic pain
Ulipristal acetate (Esmya®) single course treatment
Afatinib (Giotrif®)
Eculizumab (Soliris®)
Bosutinib (Bosulif®)
Lipegfilgrastim (Lonquex®)
Infliximab (Inflectra®)
Imiquimod 3.75% (Zyclara®)
Pertuzumab (Perjeta®)
Crizotinib (Xalkori®)
Rifaximin (Targaxan®)
Sodium phenylbutyrate (Pheburane®)
Icatibant (Firazyr®)
Perampanel (Fycompa®)
Ruxolitinib (Jakavi®)
Ocriplasmin (Jetrea®)
Linaclotide (Constella®)
Colistimethate sodium (Colobreathe®)
Vandetanib (Caprelsa®)
Apixaban (Eliquis®) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil (as fumarate)(Stribild®)
Omega-3-acid ethyl esters (Omacor®)
Levonorgestrel intrauterine system LNG-IUS (Jaydess®)
Pirfenidone (Esbriet®)
Lisdexamfetamine dimesylate (Tyvense®)
Azelastine hydrochloride and fluticasone propionate (nasal spray) (Dymista®)
Fidaxomicin (Dificlir®)
Ivacaftor (Kalydeco®)
Mirabegron (Betmiga®)
2012
Aflibercept (Eylea®)
Decitabine (Dacogen®)
Bendamustine (Levact®)
Eribulin (Halaven®)
Ingenol mebutate gel (Picato®)
Axitinib (Inlyta®)
C1inhibitor (human) (Cinryze®)
Aclidinium bromide (Eklira Genuair®)
Everolimus (Afinitor®)
Ceftaroline (Zinforo®)
Vemurafenib (Zelboraf®)
Fampridine (Fampyra®)
Ferumoxytol (Rienso®)
Glycopyrronium bromide (Seebri Breezhaler®)
Capsaicin 8%w/w patch (Qutenza®)
Apixaban (Eliquis®) for the prevention of venous thromboembolic events in adult patients who have undergone elective hip or knee replacement surgery
Rivaroxaban (Xarelto®) for the Prevention of Stroke in Atrial Fibrillation
Piperaquine tetraphosphate/dihidroartemisinin (Eurartesim®)
Abiraterone Acetate (Zytiga®) for mCRPC
Aspirin 81mg/Esomeprazole 20mg (Axanum®)
Pasireotide (Signifor®)
Tegafur/Gimeracil/Oteracil (Teysuno®)
Dexamethasone Intravitreal Implant (Ozurdex®)
Cabazitaxel (Jevtana®)
Rivaroxaban (Xarelto®) for the Treatment of Deep Vein Thrombosis
Belatacept (Nulojix®)
Telaprevir (Incivo®)
Boceprevir (Victrelis®)
Azilsartan (Edarbi®)
Rilpivirine (Edurant®)
Nomegestrol acetate/estradiol (Zoely®)
2011
Amifampridine (Firdapse®)
Denosumab (Xgeva®)
Lotemax 0.5% eye drops suspension (Loteprednol)
Regadenoson (Rapiscan®)
Everolimus (Votubia®)
Grass pollen allergen extract (Oralair®)
Ticagrelor (Brilique®)
Oncotype DX®
Fingolimod (Gilenya®)
Asenapine (Sycrest®)
Catumaxomab (Removab®)
Dexmedetomidine (Dexdor®)
Hydroxycarbamide (Siklos®)
Ipilimumab (Yervoy®)
Linagliptin (Trajenta®)
Belimumab (Benlysta®)
Dabigatran etexilate (Pradaxa®) – for the prevention of stroke and systematic embolisom in atrial fibrillation
Lornoxicam (Xefo®)
Nepafenac (Nevanac®)
Velaglucerase Alfa (VPRIV®)
Collagenase Clostridium Histolyticum (Xiapex®)
Exenatide (Bydureon®)
Adalimumab (Humira®)
Vernakalant (Brinavess®)
Tapentadol (Palexia®)
Paliperidone palmitate (Xeplion®)
Tafluprost (Saflutan®)
Retigabine (Trobalt®)
Prucalopride (Resolor®)
Bilastine (Drynol®)
Iron isomaltoside 1000 (MonoVer®)
Bazedoxifene (Conbriza®)
2010
Pitavastatin (Livazo®)
Tobramycin (TOBI Podhaler®)
Gefitinib (Iressa®)
Eltrombopag (Revolade®) for ITP
Roflumilast (Daxas®)
Corifollitropin alfa (Elonva®)
Nilotinib (Tasigna®) newly diagnosed CML
Dienogest (Visanne®)
Certolizumab pegol (Cimzia®)
Denosumab (Prolia®)
Mifamurtide (Mepact®)
Oxycodone/naloxone (Targin®)
Ofatumumab (Arzerra®) (Refractory CLL)
Golimumab (Simponi®)
Colesevelam (Cholestagel®)
Prasugrel (Efient®)
Rotavirus Vaccine
Indacaterol (Onbrez®)
Dronedarone (Multaq®)
2009
Agomelatine (Valdoxan®)
Ustekinumab (Stelara®)
Adenuric (Febuxostat®)
Ranolazine (Ranexa®)
Degarelix (Firmagon®)
Eslicarbazepine (Zebinix®)
Glucosamine sulfate (Dona®)
Colorectal Cancer Screening programme
2008
Rivaroxaban (Xarelto®) for the Primary Prevention of Venous Thromboembolic Events after Total Hip/Knee Replacement
Dabigatran Etexilate (Pradaxa®) for the Primary Prevention of Venous Thromboembolic Events after Total Hip/Knee Replacement
Melatonin (Circadin®)
Human Papillomavirus Vaccine
Nilotinib (Tasigna®) CML resistant/intolerant to imatinib
Lapatinib (Tyverb®)
2007
Sublingual Immunotherapy (Grazax®)
Natalizumab (Tysabri®)
Universal Infant Hepatitis B Vaccination programme
Pneumococcal conjugate vaccine
2006
Sunitinib (Sutent®)
Rimonabant (Acomplia®)
Inhaled insulin (Exubera®)
health check